{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:49:50Z","timestamp":1784180990322,"version":"3.55.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2016\/007966\/HS"],"award-info":[{"award-number":["EMR\/2016\/007966\/HS"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["IFA-LSBM-13"],"award-info":[{"award-number":["IFA-LSBM-13"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ajps.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T21:37:06Z","timestamp":1604957826000},"page":"397-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["An understanding of mitochondria and its role in targeting nanocarriers for diagnosis and treatment of cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Devendra","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmant","family":"Goykar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tukaram","family":"Karanwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Kannaujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedant","family":"Gadekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2020.10.002_bib0001","series-title":"Pharmaceutical applications of dendrimers","first-page":"151","article-title":"Cancer-targeted chemotherapy: emerging role of the folate anchored dendrimer as drug delivery nanocarrier","author":"Rajani","year":"2020"},{"key":"10.1016\/j.ajps.2020.10.002_bib0002","series-title":"Introduction to cancer biology","author":"Hejmadi","year":"2009"},{"key":"10.1016\/j.ajps.2020.10.002_bib0003","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.ajps.2020.10.002_bib0004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-394625-6.00008-8","article-title":"Mitochondria in cancer: why mitochondria are a good target for cancer therapy","volume":"127","author":"Dong","year":"2014","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajps.2020.10.002_bib0006","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ctrv.2008.04.003","article-title":"Multi-functional nanocarriers to overcome tumor drug resistance","volume":"34","author":"Jabr-Milane","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ajps.2020.10.002_bib0007","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajps.2020.10.002_bib0008","first-page":"4373","article-title":"Acid pH in tumors and its potential for therapeutic exploitation","volume":"49","author":"Tannock","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0009","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3389\/fphar.2018.00922","article-title":"Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment","volume":"9","author":"Battogtokh","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbamem.2007.11.002","article-title":"MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion","volume":"1778","author":"Yamada","year":"2008","journal-title":"Biochim Biophys Acta (BBA)-Biomembr"},{"key":"10.1016\/j.ajps.2020.10.002_bib0011","doi-asserted-by":"crossref","first-page":"11780","DOI":"10.1021\/acsami.6b15954","article-title":"Cancer-cell-specific mitochondria-targeted drug delivery by dual-ligand-functionalized nanodiamonds circumvent drug resistance","volume":"9","author":"Chan","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0012","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.biomaterials.2013.01.078","article-title":"The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer","volume":"34","author":"Zhou","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2020.10.002_bib0013","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1039\/C5NR01483B","article-title":"Induction of apoptosis in human cancer cells by targeting mitochondria with gold nanoparticles","volume":"7","author":"Mkandawire","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2020.10.002_bib0014","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s11671-019-3044-5","article-title":"Mitochondria-targeted and resveratrol-loaded dual-function titanium disulfide nanosheets for photothermal-triggered tumor chemotherapy","volume":"14","author":"Xiang","year":"2019","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.ajps.2020.10.002_bib0015","first-page":"498","article-title":"Nanopreparations for mitochondria targeting drug delivery system: current strategies and future prospective","volume":"12","author":"Wang","year":"2017","journal-title":"Asian J Pharm Sci"},{"issue":"3","key":"10.1016\/j.ajps.2020.10.002_bib0016","first-page":"315","article-title":"Targeted nanoparticles in mitochondrial medicine","volume":"7","author":"Pathak","year":"2015","journal-title":"Wiley Interdiscip Rev: Nanomed Nanobiotechnol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0017","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mtchem.2019.02.004","article-title":"Recent progress on mitochondrial targeted cancer therapy based on inorganic nanomaterials","volume":"12","author":"Xu","year":"2019","journal-title":"Mater Today Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0018","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/cancers11060813","article-title":"Hexokinase 2 regulates ovarian cancer cell migration, invasion and stemness via FAK\/ERK1\/2\/MMP9\/NANOG\/SOX9 signaling cascades","volume":"11","author":"Siu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ajps.2020.10.002_bib0019","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/cancers11070916","article-title":"Exploiting mitochondrial vulnerabilities to trigger apoptosis selectively in cancer cells","volume":"11","author":"Nguyen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ajps.2020.10.002_bib0020","series-title":"Cancer drug design discovery","first-page":"427","article-title":"Targeting altered metabolism\u2014Emerging cancer therapeutic strategies","author":"Seo","year":"2014"},{"key":"10.1016\/j.ajps.2020.10.002_bib0021","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","article-title":"Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells","volume":"70","author":"Ben","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0022","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.fitote.2018.01.001","article-title":"New natural inhibitors of hexokinase 2 (HK2): steroids from Ganoderma sinense","volume":"125","author":"Bao","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ajps.2020.10.002_bib0023","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/onc.2008.108","article-title":"Methyl jasmonate binds to and detaches mitochondria-bound hexokinase","volume":"27","author":"Goldin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ajps.2020.10.002_bib0024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.physiol.69.031905.163804","article-title":"Mitochondrial ion channels","volume":"69","author":"O'Rourke","year":"2007","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fchem.2018.00108","article-title":"VDAC1 as pharmacological target in cancer and neurodegeneration: focus on its role in apoptosis","volume":"6","author":"Magr\u00ec","year":"2018","journal-title":"Front Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0026","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2017.00154","article-title":"Voltage-dependent anion channel 1 as an emerging drug target for novel anti-cancer therapeutics","volume":"7","author":"Shoshan-Barmatz","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0027","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3390\/ijms19072060","article-title":"Targeting mitochondrial ion channels to fight cancer","volume":"19","author":"Bachmann","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0028","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1038\/cddis.2013.316","article-title":"VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia","volume":"4","author":"Prezma","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajps.2020.10.002_bib0029","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/1878-0261.12313","article-title":"Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy","volume":"12","author":"Shteinfer-Kuzmine","year":"2018","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0030","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1096\/fj.08-107417","article-title":"Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis","volume":"22","author":"Yuan","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ajps.2020.10.002_bib0031","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1038\/onc.2013.578","article-title":"Mitochondrial ion channels as oncological targets","volume":"33","author":"Leanza","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ajps.2020.10.002_bib0032","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fonc.2014.00302","article-title":"The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death","volume":"4","author":"Bonora","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0033","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fonc.2013.00041","article-title":"Mitochondrial permeability transition pore as a selective target for anti-cancer therapy","volume":"3","author":"Suh","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0034","doi-asserted-by":"crossref","first-page":"23071","DOI":"10.1038\/srep23071","article-title":"Mitochondrial thioredoxin system as a modulator of cyclophilin D redox state","volume":"6","author":"Folda","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajps.2020.10.002_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fonc.2017.00139","article-title":"Structure, activity regulation, and role of the mitochondrial calcium uniporter in health and disease","volume":"7","author":"Mammucari","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0036","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm3412","article-title":"Mitochondria as sensors and regulators of calcium signalling","volume":"13","author":"Rizzuto","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0037","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00424-018-2162-8","article-title":"The role of the mitochondrial calcium uniporter (MCU) complex in cancer","volume":"470","author":"Vultur","year":"2018","journal-title":"Pfl\u00fcgers Arch J Physiol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0038","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ceca.2014.09.006","article-title":"Targeting a mitochondrial potassium channel to fight cancer","volume":"58","author":"Leanza","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ajps.2020.10.002_bib0039","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1073\/pnas.0804236105","article-title":"Mitochondrial potassium channel Kv1. 3 mediates Bax-induced apoptosis in lymphocytes","volume":"105","author":"Szab\u00f3","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0040","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.18632\/oncotarget.11299","article-title":"Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma","volume":"8","author":"Zaccagnino","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajps.2020.10.002_bib0041","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbamcr.2014.02.019","article-title":"KCa and Ca2+ channels: the complex thought","volume":"1843","author":"Gueguinou","year":"2014","journal-title":"Biochim Biophys Acta (BBA)-Mol Cell Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0042","first-page":"27","article-title":"Large-conductance K+ channel openers induce death of human glioma cells","volume":"60","author":"Debska-Vielhaber","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0043","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-018-0608-2","article-title":"BCL-2 as therapeutic target for hematological malignancies","volume":"11","author":"Perini","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0044","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/14728222.2013.733001","article-title":"Targeting the Bcl-2 family for cancer therapy","volume":"17","author":"Thomas","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ajps.2020.10.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180002","article-title":"Targeting BCL-2 regulated apoptosis in cancer","volume":"8","author":"Campbell","year":"2018","journal-title":"Open Biol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0046","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2020.10.002_bib0047","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1389201011314030011","article-title":"Targeting the mitochondrial electron transport chain complexes for the induction of apoptosis and cancer treatment","volume":"14","author":"Rohlena","year":"2013","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0048","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-2-12","article-title":"Metformin directly acts on mitochondria to alter cellular bioenergetics","volume":"2","author":"Andrzejewski","year":"2014","journal-title":"Cancer Metab"},{"key":"10.1016\/j.ajps.2020.10.002_bib0049","doi-asserted-by":"crossref","first-page":"15105","DOI":"10.1074\/jbc.M117.783175","article-title":"Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1\u2013Parkin pathway and modulate cellular drug response","volume":"292","author":"Zhang","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders\u2014A step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"key":"10.1016\/j.ajps.2020.10.002_bib0051","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/iub.1493","article-title":"Rotenone induces apoptosis in human lung cancer cells by regulating autophagic flux","volume":"68","author":"Hu","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ajps.2020.10.002_bib0052","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1349-7006.2008.00771.x","article-title":"DNA polymerase \u03b3 inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells","volume":"99","author":"Sasaki","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0053","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160404","article-title":"MicroRNA-143 suppresses oral squamous cell carcinoma cell growth, invasion and glucose metabolism through targeting hexokinase 2","volume":"37","author":"Sun","year":"2017","journal-title":"Biosci Rep"},{"key":"10.1016\/j.ajps.2020.10.002_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189353","article-title":"Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218\/Bmi1 pathway","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajps.2020.10.002_bib0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbabio.2009.03.003","article-title":"Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate","volume":"1787","author":"Chen","year":"2009","journal-title":"Biochim Biophys Acta - Bioenerg"},{"key":"10.1016\/j.ajps.2020.10.002_bib0056","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajps.2020.10.002_bib0057","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1158\/1078-0432.CCR-06-1037","article-title":"Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis","volume":"12","author":"Yang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0058","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/emmm.201200235","article-title":"Inhibitors of mitochondrial Kv1. 3 channels induce Bax\/Bak-independent death of cancer cells","volume":"4","author":"Leanza","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajps.2020.10.002_bib0059","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/leu.2013.56","article-title":"Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1. 3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia","volume":"27","author":"Leanza","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ajps.2020.10.002_bib0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbapap.2008.09.023","article-title":"Proteomics analysis of A375 human malignant melanoma cells in response to arbutin treatment","volume":"1794","author":"Nawarak","year":"2009","journal-title":"Biochim Biophys Acta (BBA)-Proteins Proteom"},{"key":"10.1016\/j.ajps.2020.10.002_bib0061","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-2952(03)00248-X","article-title":"Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells","volume":"66","author":"Zhang","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0062","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-07-1919","article-title":"Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)","volume":"68","author":"Konopleva","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0063","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective Bcl-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.ajps.2020.10.002_bib0064","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","article-title":"Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia","volume":"10","author":"Konopleva","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajps.2020.10.002_bib0066","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1074\/jbc.M510249200","article-title":"Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure","volume":"281","author":"Moreira","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0067","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1074\/jbc.M117.786442","article-title":"Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition","volume":"292","author":"Trotta","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0068","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1074\/jbc.M115.697516","article-title":"Inhibition of mitochondrial complex II by the anticancer agent lonidamine","volume":"291","author":"Guo","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0069","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1038\/onc.2008.69","article-title":"\u03b1-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II","volume":"27","author":"Dong","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ajps.2020.10.002_bib0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbagen.2016.10.009","article-title":"Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells","volume":"1861","author":"del Mar Blanquer-Rossell\u00f3","year":"2017","journal-title":"Biochim Biophys Acta (BBA)-Gen Subj"},{"key":"10.1016\/j.ajps.2020.10.002_bib0071","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","article-title":"The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells","volume":"105","author":"Guzman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ajps.2020.10.002_bib0072","doi-asserted-by":"crossref","first-page":"32438","DOI":"10.1074\/jbc.C000518200","article-title":"Distinct pathways for stimulation of cytochrome c release by etoposide","volume":"275","author":"Robertson","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0073","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1073\/pnas.93.8.3592","article-title":"Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts","volume":"93","author":"Lewis","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0074","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","article-title":"Nanocarriers for cancer-targeted drug delivery","volume":"24","author":"Kumari","year":"2016","journal-title":"J Drug Target"},{"key":"10.1016\/j.ajps.2020.10.002_bib0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.lfs.2017.12.026","article-title":"Transferrin targeted liposomal 5-fluorouracil induced apoptosis via mitochondria signaling pathway in cancer cells","volume":"194","author":"Moghimipour","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0076","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mito.2019.07.005","article-title":"A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cells","volume":"49","author":"Katayama","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ajps.2020.10.002_bib0077","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/10717544.2018.1446475","article-title":"Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine\u2013docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2020.10.002_bib0078","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/acs.molpharmaceut.8b00351","article-title":"Dual-mode imaging guided multifunctional Theranosomes with mitochondria targeting for Photothermally controlled and enhanced photodynamic therapy in vitro and in vivo","volume":"15","author":"Wang","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2020.10.002_bib0079","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1039\/C8BM01020J","article-title":"Acid-active supramolecular anticancer nanoparticles based on cyclodextrin polyrotaxanes damaging both mitochondria and nuclei of tumor cells","volume":"6","author":"Bai","year":"2018","journal-title":"Biomater Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0080","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1039\/C8TB02230E","article-title":"Subcellular co-delivery of two different site-oriented payloads based on multistage targeted polymeric nanoparticles for enhanced cancer therapy","volume":"6","author":"You","year":"2018","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.ajps.2020.10.002_bib0081","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1021\/acsanm.8b00527","article-title":"Cyanine-containing polymeric nanoparticles with imaging\/therapy-switchable capability for mitochondria-targeted cancer theranostics","volume":"1","author":"Pan","year":"2018","journal-title":"ACS Appl Nano Mater"},{"key":"10.1016\/j.ajps.2020.10.002_bib0082","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/acs.biomac.8b01449","article-title":"Mitochondria targeting and destabilizing hyaluronic acid derivative-based nanoparticles for the delivery of lapatinib to triple-negative breast cancer","volume":"20","author":"Lee","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ajps.2020.10.002_bib0083","doi-asserted-by":"crossref","first-page":"43482","DOI":"10.1021\/acsami.8b17399","article-title":"Long-circulating amphiphilic doxorubicin for tumor mitochondria-specific targeting","volume":"10","author":"Xi","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0084","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1039\/C8TB02159G","article-title":"Induction of mitochondrial apoptosis for cancer therapy via dual-targeted cascade-responsive multifunctional micelles","volume":"6","author":"Wei","year":"2018","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.ajps.2020.10.002_bib0085","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1021\/acs.biomac.9b00800","article-title":"Enhanced reactive oxygen species generation by mitochondria targeting of anticancer drug to overcome tumor multidrug resistance","volume":"20","author":"Liu","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ajps.2020.10.002_bib0086","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1039\/C9CC00531E","article-title":"A mitochondria targeting artesunate prodrug-loaded nanoparticle exerting anticancer activity via iron-mediated generation of the reactive oxygen species","volume":"55","author":"Chen","year":"2019","journal-title":"Chem Commun"},{"key":"10.1016\/j.ajps.2020.10.002_bib0087","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41467-019-09566-3","article-title":"Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2020.10.002_bib0088","doi-asserted-by":"crossref","first-page":"29330","DOI":"10.1021\/acsami.9b10211","article-title":"Mitochondria-specific anticancer drug delivery based on reduction-activated polyprodrug for enhancing the therapeutic effect of breast cancer chemotherapy","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0089","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acsmacrolett.9b00121","article-title":"Trackable water-soluble prodrug micelles capable of rapid mitochondrial-targeting and alkaline pH-responsive drug release for highly improved anticancer efficacy","volume":"8","author":"Liu","year":"2019","journal-title":"ACS Macro Lett"},{"key":"10.1016\/j.ajps.2020.10.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aa8c31","article-title":"PEGylated anticancer-carbon nanotubes complex targeting mitochondria of lung cancer cells","volume":"28","author":"Kim","year":"2017","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ajps.2020.10.002_bib0091","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1039\/C6BM00878J","article-title":"Facile construction of mitochondria-targeting nanoparticles for enhanced phototherapeutic effects","volume":"5","author":"Liu","year":"2017","journal-title":"Biomater Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0092","article-title":"Glycyrrhetinic acid functionalized graphene oxide for mitochondria targeting and cancer treatment in vivo","volume":"14","author":"Zhang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ajps.2020.10.002_bib0093","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.actbio.2018.07.018","article-title":"Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect","volume":"77","author":"Han","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2020.10.002_bib0094","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1039\/C9CC05727G","article-title":"Two-dimensional supramolecular assemblies based on \u03b2-cyclodextrin-grafted graphene oxide for mitochondrial dysfunction and photothermal therapy","volume":"55","author":"Zhang","year":"2019","journal-title":"Chem Commun"},{"key":"10.1016\/j.ajps.2020.10.002_bib0095","article-title":"Retrosynthesis of tunable fluorescent carbon dots for precise long-term mitochondrial tracking","volume":"15","author":"Geng","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.ajps.2020.10.002_bib0096","doi-asserted-by":"crossref","first-page":"18368","DOI":"10.1039\/C7NR06764J","article-title":"Mitochondria-targetable carbon quantum dots for differentiating cancerous cells from normal cells","volume":"9","author":"Gao","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2020.10.002_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109824","article-title":"Facile and large-scale synthesis of graphene quantum dots for selective targeting and imaging of cell nucleus and mitochondria","volume":"103","author":"Fan","year":"2019","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.ajps.2020.10.002_bib0098","doi-asserted-by":"crossref","first-page":"e3144","DOI":"10.1002\/psc.3144","article-title":"Improved mitochondrial targeting effect of HPMA copolymer by SS20 peptide mediation and nonendocytosis pathway","volume":"25","author":"Liu","year":"2019","journal-title":"J Pept Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.005","article-title":"Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy","volume":"188","author":"Cheng","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2020.10.002_bib0100","article-title":"From nanofibers to nanorods: nanostructure of peptide-drug conjugates regulated by polypeptide-PEG derivative and enhanced antitumor effect","volume":"29","author":"Chen","year":"2019","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2020.10.002_bib0101","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.2147\/IJN.S163858","article-title":"Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes","volume":"13","author":"Shi","year":"2018","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.ajps.2020.10.002_bib0102","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/10717544.2017.1399300","article-title":"Mesoporous carbon nanomaterials in drug delivery and biomedical application","volume":"24","author":"Zhao","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2020.10.002_bib0103","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-08-1468","article-title":"Drug delivery with carbon nanotubes for in vivo cancer treatment","volume":"68","author":"Liu","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0104","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1039\/c3nr02694a","article-title":"Peptide-based carbon nanotubes for mitochondrial targeting","volume":"5","author":"Battigelli","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2020.10.002_bib0105","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1021\/acsami.7b18896","article-title":"\u201cTriple-punch\u201d anticancer strategy mediated by near-infrared photosensitizer\/CpG oligonucleotides dual-dressed and mitochondria-targeted nanographene","volume":"10","author":"Wu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0106","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2012.01.009","article-title":"Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo","volume":"159","author":"Biswas","year":"2012","journal-title":"J Control Rel"},{"key":"10.1016\/j.ajps.2020.10.002_bib0107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1081\/LPR-64958","article-title":"Mitochondriotropic liposomes","volume":"15","author":"Boddapati S","year":"2005","journal-title":"J Liposome Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0108","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2012.04.030","article-title":"Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes","volume":"432","author":"Malhi","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2020.10.002_bib0109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/wnan.1305","article-title":"Targeted nanoparticles in mitochondrial medicine","volume":"7","author":"Pathak","year":"2015","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0111","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jbm.a.33270","article-title":"Oxidative stress and apoptosis induced by hydroxyapatite nanoparticles in C6 cells","volume":"100","author":"Xu","year":"2012","journal-title":"J Biomed Mater Res Part A"},{"key":"10.1016\/j.ajps.2020.10.002_bib0112","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1021\/acsami.6b06094","article-title":"Mitochondria-targeted hydroxyapatite nanoparticles for selective growth inhibition of lung cancer in vitro and in vivo","volume":"8","author":"Sun","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0113","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1021\/acsnano.8b03212","article-title":"Precisely striking tumors without adjacent normal tissue damage via mitochondria-templated accumulation","volume":"12","author":"Ma","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2020.10.002_bib0114","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1016\/j.biomaterials.2012.03.032","article-title":"Surface conjugation of triphenylphosphonium to target poly (amidoamine) dendrimers to mitochondria","volume":"33","author":"Biswas","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2020.10.002_bib0115","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1039\/C3TB21348J","article-title":"Mitochondrial targeting dendrimer allows efficient and safe gene delivery","volume":"2","author":"Wang","year":"2014","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.ajps.2020.10.002_bib0116","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1021\/acsami.7b18437","article-title":"Overcoming multidrug resistance through the GLUT1-mediated and enzyme-triggered mitochondrial targeting conjugate with redox-sensitive paclitaxel release","volume":"10","author":"Ma","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/ar700135m","article-title":"Targeting mitochondria","volume":"41","author":"Hoye","year":"2008","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0118","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s13277-015-3719-1","article-title":"Mitochondrial targeted peptides for cancer therapy","volume":"36","author":"Farsinejad","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0119","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s13233-019-7153-x","article-title":"Cationic oligopeptide-functionalized mitochondria targeting sequence show mitochondria targeting and anticancer activity","volume":"27","author":"Bae","year":"2019","journal-title":"Macromol Res"},{"key":"10.1016\/j.ajps.2020.10.002_bib0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2020.10.002_bib0121","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1039\/C7SC03454G","article-title":"A mitochondrial-targeted prodrug for NIR imaging guided and synergetic NIR photodynamic-chemo cancer therapy","volume":"8","author":"Liu","year":"2017","journal-title":"Chem Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0122","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1039\/C8BM01414K","article-title":"Targeting mitochondria with Au\u2013Ag@ polydopamine nanoparticles for papillary thyroid cancer therapy","volume":"7","author":"Wang","year":"2019","journal-title":"Biomater Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0123","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ajps.2020.10.002_bib0124","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/EDBK_156572","article-title":"Basic Overview of current immunotherapy approaches in cancer","volume":"24","author":"Velcheti","year":"2016","journal-title":"Am Soc Clin Oncol Educ B"},{"key":"10.1016\/j.ajps.2020.10.002_bib0125","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/nn403158n","article-title":"Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy","volume":"7","author":"Marrache","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2020.10.002_bib0126","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201707249","article-title":"Size\/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration","volume":"28","author":"Dai","year":"2018","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2020.10.002_bib0127","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/1061186X.2018.1519029","article-title":"Stimuli-responsive nanoscale drug delivery systems for cancer therapy","volume":"27","author":"Li","year":"2019","journal-title":"J Drug Target"},{"key":"10.1016\/j.ajps.2020.10.002_bib0128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2016.09.026","article-title":"Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: from theoretical considerations to practical applications","volume":"241","author":"Boissenot","year":"2016","journal-title":"J Control Rel"},{"key":"10.1016\/j.ajps.2020.10.002_bib0129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.drudis.2014.01.010","article-title":"Recent progress in development of new sonosensitizers for sonodynamic cancer therapy","volume":"19","author":"Chen","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ajps.2020.10.002_bib0130","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1021\/acsami.8b21968","article-title":"Mitochondria-targeted and ultrasound-activated nanodroplets for enhanced deep-penetration sonodynamic cancer therapy","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2020.10.002_bib0131","article-title":"Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects","author":"Li","year":"2019","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0132","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biomaterials.2017.12.003","article-title":"Tumor acidity activating multifunctional nanoplatform for NIR-mediated multiple enhanced photodynamic and photothermal tumor therapy","volume":"157","author":"Liu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2020.10.002_bib0133","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1039\/C7NR06130G","article-title":"Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy","volume":"9","author":"Zhou","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2020.10.002_bib0134","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1142\/S1793984410000067","article-title":"Magnetic nanoparticle hyperthermia in cancer treatment","volume":"1","author":"Giustini","year":"2010","journal-title":"Nano Life"},{"key":"10.1016\/j.ajps.2020.10.002_bib0135","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1088\/0022-3727\/36\/13\/201","article-title":"Applications of magnetic nanoparticles in biomedicine","volume":"36","author":"Pankhurst","year":"2003","journal-title":"J Phys D Appl Phys"},{"key":"10.1016\/j.ajps.2020.10.002_bib0136","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1021\/nn503431x","article-title":"Core\u2013shell nanoparticle-based peptide therapeutics and combined hyperthermia for enhanced cancer cell apoptosis","volume":"8","author":"Shah","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2020.10.002_bib0137","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1002\/adfm.201600031","article-title":"Thermoresponsive nanogel-encapsulated PEDOT and HSP70 inhibitor for improving the depth of the photothermal therapeutic effect","volume":"26","author":"Liu","year":"2016","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2020.10.002_bib0138","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1039\/C8NR00888D","article-title":"ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy","volume":"10","author":"Rao","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2020.10.002_bib0139","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.2147\/IJN.S163858","article-title":"Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes","volume":"13","author":"Shi","year":"2018","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.ajps.2020.10.002_bib0140","series-title":"Applications of targeted nano drugs and delivery systems","first-page":"15","article-title":"Application and perspective of pH-responsive nano drug delivery systems","author":"Goyal","year":"2019"},{"key":"10.1016\/j.ajps.2020.10.002_bib0141","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1073\/pnas.95.12.6803","article-title":"Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins","volume":"95","author":"Llopis","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajps.2020.10.002_bib0142","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biomaterials.2017.07.036","article-title":"Mitochondrial alkaline pH-responsive drug release mediated by Celastrol loaded glycolipid-like micelles for cancer therapy","volume":"154","author":"Tan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2020.10.002_bib0143","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1039\/C4NR04249B","article-title":"Enzyme-responsive nanomaterials for controlled drug delivery","volume":"6","author":"Hu","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2020.10.002_bib0144","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2017.00018","article-title":"CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells","volume":"5","author":"Senbanjo","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajps.2020.10.002_bib0145","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.2147\/IJN.S202210","article-title":"Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery","volume":"14","author":"Naz","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajps.2020.10.002_bib0146","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties and regulatory issues","volume":"6","author":"Vitorino","year":"2018","journal-title":"Front Chem"},{"key":"10.1016\/j.ajps.2020.10.002_bib0147","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2020.10.002_bib0148","series-title":"The handbook of nanomedicine","first-page":"605","article-title":"Ethical and regulatory aspects of nanomedicine","author":"Jain","year":"2017"},{"key":"10.1016\/j.ajps.2020.10.002_bib0149","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087620305237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087620305237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:45:40Z","timestamp":1761723940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087620305237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":149,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1818087620305237"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2020.10.002","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An understanding of mitochondria and its role in targeting nanocarriers for diagnosis and treatment of cancer","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}